Desipramine

Depressive Disorder

New York State Psychiatric InstituteSmall moleculePhase 4 / ApprovedDormant

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 62/ 100
Competitive Position: 73/ 100

Competitive context

78 Active assets in the Depressive Disorder cohort.

Asset / Sponsor	Phase	Rating
Brexpiprazole Dr. Albert Kar-Kin Chung	Phase 4	A
Jnj-54135419 Chinese PLA General Hospital	Phase 4	BBB
Saredutant Sanofi	Phase 3	BBB
VENLOR Janssen Research & Development, LLC	Phase 4	BBB
Paroxetine Brigham and Women's Hospital	Phase 4	BBB

View all 50 →

Same molecule, other indications

Desipramine is also rated in:

irritable bowel syndromeDormant

BB

Indicative · Phase 3

64 / 100

major depressive disorderDormant

BB

Indicative · Phase 4

64 / 100

constipation disorderDormant

BB

Indicative · Phase 3

64 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.